China-based HaploX partners with Illumina to build benchtop sequencing system

US-based Illumina, a global leader in DNA sequencing and array-based technologies, and HaploX, a China-based high-tech company specialising in oncology liquid biopsy and genetic big data, have jointly announced the official launch of the first NextSeq 2000Dx-CN-HAP, a domestically-produced genetic sequencing system, in Shenzhen.

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localised manufacturing of high-end life science instruments as a new starting point, focus on scientific research and innovation, and leverage the advantages of the Guangdong-Hong Kong-Macao Greater Bay Area, to jointly support the development of China's life sciences and medical innovation into a new stage.

According to the Outline Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area, by 2035, the development of the Greater Bay Area will be primarily driven by innovation, and it will take deep participation in international cooperation to build an international science and technology innovation center, enhancing global influence. 

Shenzhen, as a central point in the regional science and technology innovation landscape, gathers international innovation resources and focuses on emerging industries such as high-performance medical devices, genetic sequencing, bioinformatics analysis, etc., aiming to create a new highland for biomedical innovation in China.

NextSeq 2000 sequencing system incorporates over 75 technological innovations and integrates bioinformatics analysis capabilities with the onboard DRAGEN server, enabling complete library amplification, sequencing, and rapid genomic analysis in a one-stop manner. 

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!